美股詳情

本頁面由Tiger Fintech (Singapore) Pte. Ltd.提供服務

Kurv Yield Premium Strategy Tesla (TSLA) ETF

20.69

+0.06200.30%

盤後：20.690.00000.00%19:39 EDT

成交量：2.07萬

成交額：42.75萬

市值：2,131.07萬

市盈率：- -

高：20.85

開：20.80

低：20.55

收：20.63

52周最高：34.29

52周最低：15.36

股本：103.00萬

流通股本：103.00萬

量比：1.09

換手率：2.01%

股息：8.85

股息率：42.77%

淨資產收益率：--

總資產收益率：--

市淨率：--

市盈率(LYR):- -

資料載入中...

總覽公司新聞公告

概念

no data

沒有相關數據

資金流向

資金流入：

資金流出：

新聞

大行評級｜交銀國際：上調康諾亞目標價至78港元上半年核心品種市場滲透加速

和鉑醫藥公佈2025年中期業績

中國生物製藥(01177)將於ERS 2025公佈“TQC3721 (PDE3/4抑制劑)”、“TQC2731 (TSLP單抗)”、“TQC3403 (烏美溴銨維蘭特羅吸入粉霧劑)”研究成果

科倫博泰生物-B：商業化步入收穫期核心臨牀佈局迎來收穫期

{"basename":"/hant","ssrTDKData":{"titleTemplate":"%s - 老虎證券","title":"老虎证券全球投资理财平台| 一站式投资美股新股港股A股","description":"老虎证券助您一站式投资美股，新股，港股，A股等全球金融理财产品。新加坡华人最信赖的在线投资平台，现在加入即享低费用，24/5 无时差炒美股投资理财！","keywords":"老虎證券,老虎證券開戶,老虎券商,老虎證券官網,老虎證券app,tigertrade老虎證券,股票,炒股,新加坡股票交易平臺,投資,投資理財","social":{"ogDescription":"老虎证券助您一站式投资美股，新股，港股，A股等全球金融理财产品。新加坡华人最信赖的在线投资平台，现在加入即享低费用，24/5 无时差炒美股投资理财！","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.be62fbe1.png","ogUrl":"https://www.itiger.com/hant/stock/TSLP"},"companyName":"老虎證券"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"SGP","license":"TBSG","edition":"fundamental","symbol":"TSLP","isAnalysisPage":false},"__swrFallback__":{"@#url:\"https://hq.skytigris.cn/stock_info/detail/global\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"TSLP\",,,,,undefined,":{"symbol":"TSLP","market":"US","secType":"STK","nameCN":"Kurv Yield Premium Strategy Tesla (TSLA) ETF","latestPrice":20.69,"timestamp":1757448000000,"preClose":20.628,"halted":0,"volume":20682,"hourTrading":{"tag":"盘后","latestPrice":20.69,"preClose":20.69,"latestTime":"19:39 EDT","volume":11,"amount":226.98,"timestamp":1757461150172},"delay":0,"floatShares":1030000,"shares":1030000,"eps":0,"marketStatus":"未開盤","change":0.062,"latestTime":"09-09 16:00:00 EDT","open":20.8,"high":20.85,"low":20.5501,"amount":427525.48115999997,"amplitude":0.014538,"askPrice":0,"askSize":0,"bidPrice":0,"bidSize":0,"shortable":3,"etf":1,"ttmEps":0,"tradingStatus":0,"nextMarketStatus":{"tag":"盤前交易","tradingStatus":1,"beginTime":1757491200000},"marketStatusCode":0,"adr":0,"exchange":"AMEX","adjPreClose":20.628,"sharesOutstanding":1030000,"nav":20.65,"aum":21269500,"dividendRate":0.427743,"bidAskSpread":0,"preHourTrading":{"tag":"盘前","latestPrice":20.73,"preClose":20.628,"latestTime":"09:07 EDT","volume":3,"amount":61.89,"timestamp":1757423239703},"postHourTrading":{"tag":"盘后","latestPrice":20.69,"preClose":20.69,"latestTime":"19:39 EDT","volume":11,"amount":226.98,"timestamp":1757461150172},"volumeRatio":1.087805,"impliedVol":0.2602,"impliedVolPercentile":0.4177},"@#url:\"https://hq.skytigris.cn/stock_info/fundamental/all\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"TSLP\",,,,,undefined,":{"symbol":"TSLP","floatShares":1030000,"roa":"--","roe":"--","lyrEps":0,"volumeRatio":1.087805,"shares":1030000,"dividePrice":8.85,"high":20.85,"amplitude":0.014538,"preClose":20.628,"low":20.5501,"week52Low":15.36,"pbRate":"--","week52High":34.2895,"institutionHeld":0,"latestPrice":20.69,"eps":0,"divideRate":0.427743,"volume":20682,"delay":0,"ttmEps":0,"open":20.8,"prevYearClose":30.27,"prevWeekClose":20.81,"prevMonthClose":20.22,"prevQuarterClose":20.31,"fiveDayClose":20.09,"twentyDayClose":20.41,"sixtyDayClose":20.1528},"@#url:\"https://hq.skytigris.cn/fundamental/corporate_actions/details/TSLP\",params:#limit:5,,,undefined,":[{"date":"2025-09-03","symbol":"TSLP","amount":0.45,"announcedDate":"2025-09-02","type":"dividend","lastAmount":null,"market":"US","newRecordDate":"2025-09-03","defaultRemindTime":1756906200000,"name":"Kurv Yield Premium Strategy Tesla (TSLA) ETF","lastCurrency":null,"lastExecuteDate":null,"recordDate":"2025-09-04","payableDate":"2025-09-03","currency":"USD","dateTimestamp":1756872000000,"payDate":"2025-09-04"},{"date":"2025-08-06","symbol":"TSLP","amount":0.45,"announcedDate":"2025-08-05","type":"dividend","lastAmount":null,"market":"US","newRecordDate":"2025-08-06","defaultRemindTime":1754487000000,"name":"Kurv Yield Premium Strategy Tesla (TSLA) ETF","lastCurrency":null,"lastExecuteDate":null,"recordDate":"2025-08-07","payableDate":"2025-08-06","currency":"USD","dateTimestamp":1754452800000,"payDate":"2025-08-07"},{"date":"2025-07-02","symbol":"TSLP","amount":0.45,"announcedDate":null,"type":"dividend","lastAmount":null,"market":"US","newRecordDate":"2025-07-02","defaultRemindTime":1751463000000,"name":"Kurv Yield Premium Strategy Tesla (TSLA) ETF","lastCurrency":null,"lastExecuteDate":null,"recordDate":"2025-07-03","payableDate":"2025-07-02","currency":"USD","dateTimestamp":1751428800000,"payDate":"2025-07-03"},{"date":"2025-06-04","symbol":"TSLP","amount":0.5,"announcedDate":null,"type":"dividend","lastAmount":null,"market":"US","newRecordDate":"2025-06-04","defaultRemindTime":1749043800000,"name":"Kurv Yield Premium Strategy Tesla (TSLA) ETF","lastCurrency":null,"lastExecuteDate":null,"recordDate":"2025-06-05","payableDate":"2025-06-04","currency":"USD","dateTimestamp":1749009600000,"payDate":"2025-06-05"},{"date":"2025-05-07","symbol":"TSLP","amount":0.55,"announcedDate":"2025-05-06","type":"dividend","lastAmount":null,"market":"US","newRecordDate":"2025-05-07","defaultRemindTime":1746624600000,"name":"Kurv Yield Premium Strategy Tesla (TSLA) ETF","lastCurrency":null,"lastExecuteDate":null,"recordDate":"2025-05-08","payableDate":"2025-05-07","currency":"USD","dateTimestamp":1746590400000,"payDate":"2025-05-08"}],"@#url:\"https://hq.skytigris.cn/fundamental/dividend/history\",params:#symbol:\"TSLP\",market:\"US\",,,undefined,":[{"executeDate":"2023-11-22","recordDate":"2023-11-24","paymentDate":"2023-11-27","value":0.5775,"currency":"USD"},{"executeDate":"2023-12-20","recordDate":"2023-12-21","paymentDate":"2023-12-22","value":0.6664,"currency":"USD"},{"executeDate":"2024-01-24","recordDate":"2024-01-25","paymentDate":"2024-01-26","value":0.5555,"currency":"USD"},{"executeDate":"2024-02-21","recordDate":"2024-02-22","paymentDate":"2024-02-23","value":0.313,"currency":"USD"},{"executeDate":"2024-03-20","recordDate":"2024-03-21","paymentDate":"2024-03-22","value":0.5189,"currency":"USD"}],"@#url:\"https://hq.skytigris.cn/fundamental/estimate/recommendation\",params:#symbol:\"TSLP\",market:\"US\",delay:false,,,undefined,":{},"$inf$@#url:\"https://stock-news.skytigris.cn/v2/news/list\",params:#symbols:\"TSLP\",pageSize:4,pageCount:1,lang_content:\"cn\",edition:\"fundamental\",,,undefined,":[{"items":[{"id":"2563947470","title":"大行評級｜交銀國際：上調康諾亞目標價至78港元 上半年核心品種市場滲透加速","url":"https://stock-news.laohu8.com/highlight/detail?id=2563947470","media":"格隆汇","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2563947470?lang=zh_tw&edition=fundamental","pubTime":"2025-08-29 11:13","pubTimestamp":1756437220,"startTime":"0","endTime":"0","summary":null,"market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.gelonghui.com/rss/live/live.xml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"live_gelonghui","symbols":["02162","BK1583","BK1574","DCF","BK1161","BK1587","TSLP"],"gpt_icon":0},{"id":"2562775218","title":"和鉑醫藥公佈2025年中期業績","url":"https://stock-news.laohu8.com/highlight/detail?id=2562775218","media":"美通社","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2562775218?lang=zh_tw&edition=fundamental","pubTime":"2025-08-27 22:40","pubTimestamp":1756305600,"startTime":"0","endTime":"0","summary":"中国上海、美国马萨诸塞州剑桥和荷兰鹿特丹2025年8月27日 /美通社/ -- 和铂医药，一家专注于免疫性疾病及肿瘤领域创新药研发的全球生物医药公司，今日公布其2025年中期业绩。报告期内，公司盈利同比增长超50倍，展现出强劲的增长态势。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://wwwold.prnasia.com/story/archive/4759969_ZH59969_1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"prnasia","symbols":["BK1161","LU2065731478.USD","BK1583","CRS","BK1574","IE00B66KJ199.SGD","BK4213","BK4006","IE00B19Z4B17.USD","LU0963586101.USD","IE00B7SZL793.SGD","MSS","BK4113","SD","02142","IE0031619046.USD","TSLP"],"gpt_icon":0},{"id":"2562243570","title":"中國生物製藥(01177)將於ERS 2025公佈“TQC3721 (PDE3/4抑制劑)”、“TQC2731 (TSLP單抗)”、“TQC3403 (烏美溴銨維蘭特羅吸入粉霧劑)”研究成果","url":"https://stock-news.laohu8.com/highlight/detail?id=2562243570","media":"智通财经","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2562243570?lang=zh_tw&edition=fundamental","pubTime":"2025-08-25 18:39","pubTimestamp":1756118386,"startTime":"0","endTime":"0","summary":"智通财经APP讯，中国生物制药(01177)公布，集团开发的“TQC3721 (PDE3/4抑制剂)”、“TQC2731 (TSLP单抗)”、“TQC3403 (乌美溴铵维兰特罗吸入粉雾剂)”将于9月27日至10月1日举行的2025年欧洲呼吸学会年会 (ERS 2025)公布4项研究成果。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1334588.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["BK1589","01177","IE00BZ08YR35.GBP","BK1191","IE00BZ08YS42.EUR","BK1521","TSLP","BK1515","IE00BZ08YT58.USD"],"gpt_icon":0},{"id":"2560106411","title":"科倫博泰生物-B：商業化步入收穫期 核心臨牀佈局迎來收穫期","url":"https://stock-news.laohu8.com/highlight/detail?id=2560106411","media":"国金证券","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2560106411?lang=zh_tw&edition=fundamental","pubTime":"2025-08-20 00:00","pubTimestamp":1755619200,"startTime":"0","endTime":"0","summary":"经营分析商业化元年，销售迎来起量。公司目前已有佳泰莱、科泰莱、达泰莱3 款产品获批上市；业务已覆盖30 个省份、300 余个地级市以及2000 余家医院。佳泰莱、科泰莱、达泰莱均已通过基本医保目录初步形式审查，纳入医保后有望进一步迎来加速放量。数据催化密集，佳泰莱核心临床布局迎来收获期。维持“买入”评级。风险提示新药研发不达预期；海外进展不达预期；商业化放量不及预期。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250820181123a6f0f8c4&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250820181123a6f0f8c4&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["TSLP"],"gpt_icon":0}],"pageSize":4,"totalPage":2,"pageCount":1,"totalSize":6,"code":"91000000","status":"200"}],"@#url:\"https://hq.skytigris.cn/market/plate/belongs/TSLP\",params:#limit:6,delay:false,,,undefined,":[]}}